On October 9, the team said that VitaDAO, a decentralized science (DeSci) DAO, has launched Matrix Biosciences, a biotech company, in partnership with Vera Gorbunova of the University of Rochester’s Aging Research Center. With an initial $300,000, they will research molecules based on hyaluronic acid with the goal of breaking new ground in the fight against cancer and aging. They will draw inspiration from cancer-resistant naked mole rats. According to the press statement, “further funding through IP-NFT fractionalization funding in early 2024” is anticipated.
The Protocol, a weekly newsletter that examines the technology underlying cryptocurrency one block at a time, frequently includes Protocol Village. To receive it in your inbox every Wednesday, sign up here. Updates can be sent here by project teams.
